✦ LIBER ✦

Prediction of nonSVR to therapy with pegylated interferon-α2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment

✍ Scribed by E. Lukasiewicz; M. Gorfine; L. S. Freedman; J.-M. Pawlotsky; S. W. Schalm; C. Ferrari; S. Zeuzem; A. U. Neumann; for the DITTO-HCV Study Group

Book ID: 108886334
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 136 KB
Volume: 17
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2009.01183.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized controlled trial of pegylat

A randomized controlled trial of pegylated interferon α-2a (40 KD) or interferon α-2a plus ribavirin and amantadine vs interferon α-2a and ribavirin in treatment-naïve patients with chronic hepatitis C

✍ A. Mangia; G. L. Ricci; M. Persico; N. Minerva; V. Carretta; D. Bacca; M. Cela; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Treatment effects and predictors of a 24

Treatment effects and predictors of a 24-week course of interferon α-2b plus ribavirin combination therapy for patients with chronic hepatitis C

✍ Masahiko Tomimatsu; Yoshio Aizawa; Yoshimichi Chuganji; Hideo Ishizuka; Yoshiyuk 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

A randomized trial of pegylated-interfer

A randomized trial of pegylated-interferon-α2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin

✍ A. CIANCIO; A. PICCIOTTO; C. GIORDANINO; A. SMEDILE; M. TABONE; A. MANCA; G. MAR 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

Pegylated interferon alpha-2b plus ribav

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response

✍ Sanaa M. Kamal; Samer S. El Kamary; Michelle D. Shardell; Mohamed Hashem; Imad N 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 2 views

In patients chronically infected with hepatitis C virus (HCV) genotype 4, the optimum duration of therapy and the predictors of sustained virologic response (SVR) have not been adequately determined. In this study, 358 patients with chronic hepatitis C genotype 4 were randomly assigned to pegylated

Effective prediction of outcome of combi

Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices

✍ Hideyuki Nomura; Yugo Miyagi; Hironori Tanimoto; Masashi Higashi; Hiromi Ishibas 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 391 KB

Effects of ribavirin combined with inter

Effects of ribavirin combined with interferon-α2b on viral kinetics during first 12 weeks of treatment in patients with hepatitis C virus genotype 1 and high baseline viral loads

✍ M. Enomoto; S. Nishiguchi; M. Kohmoto; A. Tamori; D. Habu; T. Takeda; S. Seki; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB